These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 5388724)

  • 21. A pointed clue.
    Indik JH
    Am J Med; 2005 Nov; 118(11):1221-2. PubMed ID: 16271904
    [No Abstract]   [Full Text] [Related]  

  • 22. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.
    Bennett LN; Myers TF; Lambert GH
    Am J Perinatol; 1996 Apr; 13(3):167-70. PubMed ID: 8688109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Case of renal insufficiency treated with peritoneal perfusion and administration of cation exchange resin in a child].
    Okumura T; Onodera H; Okumura M; Yoshino T; Teshirogi T
    Nihon Ishikai Zasshi; 1968 Oct; 60(8):759-66. PubMed ID: 5751709
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperkalemia and hypokalemia.
    Newmark SR; Dluhy RG
    JAMA; 1975 Feb; 231(6):631-3. PubMed ID: 1172849
    [No Abstract]   [Full Text] [Related]  

  • 26. [A successfully treated case of spironolactone-induced hyperkalemic quadriplegia].
    Radó J; Csabuda M
    Orv Hetil; 1985 Aug; 126(32):1967-70, 1973-4. PubMed ID: 2993981
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate.
    Nguyen T; Ondrik D; Zhufyak O; To W; He S
    JAAPA; 2015 Mar; 28(3):41-5. PubMed ID: 25710403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hyperkalemia in patients with chronic kidney disease--a focus on medications.
    Raymond CB; Sood AR; Wazny LD
    CANNT J; 2010; 20(3):49-53; quiz 54-5. PubMed ID: 21038829
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.
    Little DJ; Nee R; Abbott KC; Watson MA; Yuan CM
    Clin Nephrol; 2014 Apr; 81(4):259-68. PubMed ID: 24656316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary hyperkalaemic acute flaccid tetraplegia].
    Berrebi R; Orban JC; Levraut J; Grimaud D; Ichai C
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):381-3. PubMed ID: 19304442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose and insulin versus cation-exchange resin for the treatment of hyperkalemia in very low birth weight infants.
    Malone TA
    J Pediatr; 1991 Jan; 118(1):121-3. PubMed ID: 1986079
    [No Abstract]   [Full Text] [Related]  

  • 33. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
    Yaseen H; Khalaf M; Dana A; Yaseen N; Darwich M
    Am J Perinatol; 2008 Mar; 25(3):193-7. PubMed ID: 18425722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperkalemic emergency: causes, diagnosis and therapy].
    Tamm M; Ritz R; Thiel G; Truniger B
    Schweiz Med Wochenschr; 1990 Jul; 120(29):1031-6. PubMed ID: 2374893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.
    Fassinger N; Dabbagh S; Mukhopadhyay S; Lee DY
    Adv Perit Dial; 1998; 14():274-7. PubMed ID: 10649740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrotizing enterocolitis in a 850 gram infant receiving sorbitol-free sodium polystyrene sulfonate (Kayexalate): clinical and histopathologic findings.
    Rugolotto S; Gruber M; Solano PD; Chini L; Gobbo S; Pecori S
    J Perinatol; 2007 Apr; 27(4):247-9. PubMed ID: 17377608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PERITONEAL DIALYSIS AND HEMODIALYSIS.
    TESCHAN PE
    Mod Treat; 1964 Jan; 1():100-6. PubMed ID: 14161705
    [No Abstract]   [Full Text] [Related]  

  • 38. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.
    Nakayama Y; Ueda K; Yamagishi SI; Sugiyama M; Yoshida C; Kurokawa Y; Nakamura N; Moriyama T; Kodama G; Minezaki T; Ito S; Nagata A; Taguchi K; Yano J; Kaida Y; Shibatomi K; Fukami K
    Clin Exp Nephrol; 2018 Feb; 22(1):35-44. PubMed ID: 28421299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vivo studies with a cation exchange resin mixture in the removal of excessive ammonium from the extracorporeal circulation system.
    Juggi JS
    Aust N Z J Surg; 1971 Nov; 41(2):194-201. PubMed ID: 5288423
    [No Abstract]   [Full Text] [Related]  

  • 40. [Variations in plasma electrolytes during cation exchange resin therapy in nephrosis in children].
    FRIED I; SALA I
    Boll Soc Ital Biol Sper; 1954 Mar; 30(3):203-5. PubMed ID: 13182049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.